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AN ASSESSMENT OF PIPETTE CALIBRATION STABILITY USING 
STATISTICAL PROCESS CONTROL CHARTS 
 
 
RACHEL EILEEN PRUCKLER 
 
ABSTRACT 
Routine pipette calibration is an essential part of any quality assurance and quality 
control program in the forensic sciences and beyond.  Pipette calibration standards in a 
forensic laboratory are typically set to the limits outlined by the document ISO8655, 
published by the International Organization for Standardization for the general scientific 
community.  Alternative methods exist that may be capable of monitoring pipette 
stability across time in a forensic setting.  Statistical process control charts, or Shewhart 
charts, are one such form of process control, which is being investigated for its potential 
application to pipette calibration monitoring for forensic DNA laboratories.  Indeed, the 
application of process control lines for monitoring the calibration of volumetric 
equipment is not without precedent.
1
     
To investigate the applicability of process control charts for monitoring pipette 
stability, a series of    and S charts, a type of Shewhart chart, have been produced from 
eight years of collected calibration data.  A total of 71 pipettes of the following sizes 
were examined: 1-10 µL, 1-10 µL multi-channel, 10-100 µL, 100-1000 µL, 1-3 µL, 30-
300 µL, 5-50 µL, 5-50 µL multi-channel, and 500-5000 µL pipettes.  The ISO8655 
calibration recommended volume limits of these pipettes have been added to the charts 
for the purposes of comparison.  With these charts, it is possible to assess pipette 
vi 
performance over time in comparison to the ISO8655 calibration standards and to the 
control limits imposed by the Shewhart charts.  The completed charts suggest that the 
methodology proposed by Shewhart shows promise as a supplement to ISO8655 
recommendations for monitoring pipette stability across time. 
To corroborate the value of using Shewhart charts to monitor pipette performance, 
a serial dilution study in conjunction with a series of simulations with dynamic modeling 
software was performed.  This dilution study investigated whether the systematic biases 
shown by the Shewhart charts could be measured in a laboratory setting.  The simulations 
investigated multiple hypothetical pipetting scenarios concerning various levels of 
systematic bias.  The simulations consistently corroborated the value of Shewhart charts 
to enforce better compliance between a pipette’s nominal and actual volume delivery, 
while the serial dilution study offered partial evidence of systematic pipetting bias.   
vii 
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1. INTRODUCTION 
1.1 The Importance of QA/QC, Calibration, and the Quantification of Uncertainty  
In many scientific disciplines, including biology and chemistry, the accurate and 
precise transfer of minute volumes of liquid with pipettes is essential for correct 
experimentation.  Ensuring consistent pipette performance over time with routine 
calibrations is necessary to ensure continued quality of scientific work.  The forensic 
science community is no exception, with sub-disciplines like forensic DNA analysis, 
chemistry, and toxicology all depending on accurate volume sampling as a part of routine 
scientific analysis in casework.  In forensic science, which applies science to matters of 
the law, the need for precision and accuracy cannot be overstated.  The legal value of 
scientific interpretation of evidence to support innocence or guilt of the accused has far-
reaching implications and depends on accuracy, reliability, and precision in 
measurement.  Imprecise and inaccurate measurements with pipettes may skew results 
and hinder the dependability of subsequent tests.    
Thus is the need for rigorous standards of control on all facets of the scientific 
endeavor, especially with the introduction of high-throughput laboratory screening.  
Quality assurance, or QA, entails the entire scope of practices put in place to avoid the 
introduction of error and ensure the reliability of results, compromising between what is 
desirable and what is attainable.  In contrast, QC, or quality control, is concerned with the 
identification of process defects and errors as they occur.
2
  The sources of error in the 
laboratory are multitude, resulting in the investment of much time and labor into 
identifying causes and creating methods for error mitigation.  For example, the 
2 
importance of quality reference standards is discussed by Paul Lee et al, who elaborate on 
the requirement for quality reference standards for the calibration of 
2
H/
1
H analysis in 
isotope ratio mass spectrometry.  If the accuracy of a reference standard is in doubt such 
as Paul Lee et al demonstrated with deuterium oxide, then any subsequent calibration 
procedure would also be in doubt.
3
    
Beyond the need for accurate reference standards to ensure quality calibrations, 
several authors explore the mathematical aspect of how calibrations are produced and 
what errors may be introduced as a result.  As discussed by Hyk and Stojek, the quality 
and reliability of analytical results are closely linked to the proper statistical treatment of 
data in the calibration process.  Several assumptions are made about the data to simplify 
the analysis, such as the assumption of homogeny of precision across an instrument’s 
working range and the assumption that the uncertainty of the x-variable is minor 
compared to that of the y-variable of the measurement.  However, data rarely conforms to 
these assumptions in real life.  Offering a method for correcting for multiple 
uncertainties, Hyk and Stojek present several equations for the production of calibration 
curves from experimental data that account for uncertainties in both the x and y axes.  
They demonstrate that, using Monte Carlo simulation modeling, their equations are valid 
and useful for the detection of leads, arsenic, and iron.
4
 
Riu and Rius also explore the impact of two-axes bias on the process of method 
comparison.  Their work compares the calibration curves produced by bivariate least 
squares to those produced by ordinary least squares and weighted least squares.  With 
case examples, the authors demonstrate that utilizing ordinary least squares or weighted 
3 
least squares may erroneously support or refute the hypothesis that two laboratory 
methodologies are similar.  In one example case, the authors explore the ramifications of 
measuring arsenic in natural water with different forms of atomic absorption 
spectrometry, concluding that bivariate least squares supported the similarity of the two 
spectrometry methods while ordinary and weighted least squares erroneously refuted 
their similarity.  With this established, the authors postulate that scientific literature may 
be full of erroneously deemed traceable or accurate methods, produced by statistical 
techniques that do not account for errors on both axes.
5
 
      Gelman, Chew, and Shnaidman explore the accumulation of errors in 
calibration curves by employing Bayesian methods to estimate unknown samples in a 
serial dilution assay.  Current methods for extrapolating the concentration of an unknown 
sample straight off of a calibration curve ignore measurement error, which may be 
elevated at high concentrations. While data points outside of the detection limits are 
usually discarded, Bayesian inference makes better use of these data by compensating for 
elevated uncertainty at very high or low concentrations and by incorporating multiple 
sources of variation without the need for error-producing linearization. Thus, this 
Bayesian method can restore data that would otherwise need to be discarded as below 
detection limit.  Further, this method can distinguish between low concentrations and 
concentrations of 0, important for the detection of trace contaminants such as allergens 
for asthma sufferers.
6
    
Hernández-Caraballo, Rivas, and Ávila de Hernández also explore the usefulness 
of extending calibration curves, this time for the extension of the working calibration 
4 
range of cadmium in graphite furnace atomic absorption spectrometry.  Atomic 
absorption spectrometry is used to detect atomic species in trace quantities, but is 
hampered by a short linear dynamic range.  Such a short range requires that samples be 
diluted, increasing time, cost, and the risk of contamination.  Thus, the generalized  
regression artificial neural network model was produced to successfully model 
cadmium’s nonlinear calibration curve and extend the upper concentration limit.7      
Exploration of the accuracy of serial dilutions was performed by Walling.  Serial 
dilutions are prone to propagation error and this, combined with assumptions about 
quality control parameters, can lead to erroneous results.  As dose-response curves are 
traditionally made with serial dilutions, it is necessary to ensure that error is controlled to 
ensure quality of results.  Quality of data is determined by the quality of liquid handling, 
so even a liquid handler that passes general single-dispense QC may still introduce 
dispensing, mixing, and carry-over errors into the serial dilution.  Walling’s QC method 
for dilution plates successfully accounts for the nonlinearity of compounds solubilized in 
dimethyl sulfoxide, or DMSO, for dose-response curves.
8
    
Many are the sources of error in laboratory work, and many are the methods 
employed to identify or account for them.  Pipettes and other volumetric devices, of 
course, are no exception to the need for monitoring as a part of QA/QC, as discussed 
next.  Meyer, Pfohl, and Winter investigate the multiple contributing factors to 
volumetric delivery from glassware as it relates to maximum permissible error.  The 3 
contributors to uncertainty for glassware include calibration, repeatability, and 
temperature effect.  The maximum permissible error combines deviations from the 
5 
nominal value and handling reproducibility, but does not account for temperature.  Thus, 
the authors propose a series of equations to holistically combine the effects of 
temperature and maximum permissible error to determine measurement uncertainty with 
volumetric glassware.
9
   
Exploration of pipettes, both manual and automated, is also explored by the 
literature.  Stangegaard et al. propose a simple method for the validation and verification 
of automated liquid handler-mounted pipettes in accordance with ISO17025 standards.  
The authors made note of several sources of pipetting error during their study, including 
how fixed Teflon-coated pipette tips demonstrated great variation between pipettes, with 
their performance being corrected with the exchange of system liquid filters and the 
testing of the pipette pumps.  Manual pipetting was also initially employed to verify the 
automated liquid handler, but it was established that manual pipetting consistently 
delivered quantities below the nominal volume.  The authors postulate that this was due 
to poor manual technique or the transfer of body heat during operation.  The authors 
concluded that automated liquid handlers are suitable for advanced and precise 
pipetting.
10
  
1.2 ISO recommendations within QA/QC  
 As a part of QA/QC in various scientific fields, ISO publishes documents 
outlining minimum requirements and recommendations.  One document, ISO8655, 
specifies general requirements for the use of pipettes and other piston-operated 
volumetric devices, including guidelines for routine calibration.  Of particular importance 
to pipette calibration are the metrological limits such as maximum permissible error, 
6 
which describes the upper and lower permissible extremes of value deviation from the 
nominal volume.  Many scientific disciplines, including forensic DNA analysis, 
implement ISO8655 recommendations for the calibration of pipettes.
11
 
 As ISO8655 represents a collection of standards for application across multiple  
scientific disciplines, it is unknown whether ISO8655 recommendations alone are 
sufficient to ensure quality of liquid handling in forensic DNA analysis.  Other methods 
to monitor precision, accuracy, and process stability exist and have yet to be explored for 
employment in the forensic sciences.  Statistical process control charts represent one such 
form of process control that may be applicable as an alternative method to ensure pipette 
stability in a forensic DNA laboratory.   
1.3 Statistical Process Control 
Statistical process control charts, or Shewhart charts, were first developed by Dr. 
Walter Shewhart at Bell Laboratories in the 1920s as a method for visualizing feedback 
on a process to prevent process errors,
12
 later published in his 1931 book Economic 
Control of Quality of Manufactured Product.  Statistical process control (SPC) serves to 
detect changes in the distribution of critical measurements early, so to prevent the 
production of discrepant outcomes.  If implemented properly, SPC allows for the prompt 
detection of process deviations and saves time and resources for the user.  As such, SPC 
is pivotal for total quality management.   
Control charts visualize conformity and deviation from a standard for a product or 
process using repeated measurements collected over time.  In a dynamic environment, the 
effects of assignable causes, such as tool wear or operator error, and random events, such 
7 
as changes in ambient conditions, produce measureable variations from the expected 
outcome that can become evident on a control chart for a given sample.  Measurements 
taken deliberately over a short period of time minimize the variability of assignable 
causes.  Different samples collected at divergent times and under divergent conditions 
correspondingly maximize the effects of assignable causes.  Rational subgroups, as 
described by Shewhart, describe the collections of measurements taken to minimize the 
impact of assignable causes within subgroups and maximize it between subgroups.  This 
is to maximize the detection of variability between subgroups over time and minimize 
interference of these same variances within a subgroup.
13
   
1.4 Control Chart Selection 
Many types of control charts exist and each serves a specific function.  Variable 
data, also known as measurable data, may be examined with    and R charts or    and S 
charts.  Attributes data, also known as qualitative data, may also be examined with 
Shewhart charts.  Types of control charts for attribute data include c-charts, u-charts, p-
charts, and np-charts.
12
  
 Control charts for variables are produced in pairs.  The    chart plots the averages 
of the rational subgroups across the appropriate timeframe.  The R chart or S chart plots 
the ranges or standard deviations respectively of each subgroup across the same period.
13 
R charts are best for small subgroups of constant size, usually between two and five 
measurements per subgroup.  S charts more efficiently measure process variability for 
large sample sizes, but are less sensitive to variations caused by a single measurement 
within a subgroup.
12
     
8 
1.5 Construction of a Shewhart Chart 
The equations for constructing an    and S chart are described below.  The  
equations below demonstrate how to calculate the upper and lower control limits (UCL  
and LCL respectively) of an    chart with an attendant S chart (Equations 1-3): 
           
  
      
           (1) 
           
  
      
           (2) 
                        (3) 
The symbol    represents the grand mean of the total subgroups, or the average of the 
averages, which is plotted on the    chart as the center line.  The variable n represents the 
number of measurements taken for a single subgroup.
14
 The value 3, usually represented 
by the variable k, is the distance of the control limits from the center line   .  Three is the 
accepted industry standard for the constant k.
  
C4 is a correctional constant meant to 
estimate the population standard deviation σ from the sample standard deviation S.  C4 is 
calculated as follows (Equation 4): 
     
 
   
   
 
 
 
    
 
   
 
    
          (4) 
C4 is also dependent on the sample size n.
15
  
The UCL and LCL for the S chart are calculated as follows (Equations 5-7): 
         
  
  
                   (5) 
         
  
  
                    (6) 
                       (7) 
9 
Here,    is the average of the standard deviations of the subgroups collected.  The values 
of k and C4 match as described previously.
14
   
 In the literature, it is common to see the many constants used to calculate the  
control limits to be condensed into a single constant.  This simplified equation for the     
chart is shown below (Equation 8): 
                       (8) 
The value A3 is a constant that condenses the following (Equation 9): 
    
 
      
           (9) 
The simplified equations for the    chart are as follows (Equations 10 and 11): 
                     (10) 
                     (11) 
The constants B3 and B4 are condensed from the following (Equations 12 and 13): 
      
        
 
  
          (12) 
      
        
 
  
          (13) 
The value    is calculated same as before, being the mean of the standard deviations.16 
When constructing a Shewhart chart, data must be collected when the process is 
thought to be in statistical control, that is, the distribution of the subgroups remains 
stable.  This is done by plotting the data—the same data used to calculate the control 
limits—on the charts themselves.  Should any point fall outside of the control limits, then 
the chart must not be used for monitoring purposes and the process must be investigated 
10 
for potential assignable causes.  Out-of-control points with identified assignable causes 
may be excluded and the control limits recalculated.
17
 
1.6 Interpreting Control Charts 
As previously described,    and S control charts plot the average value and  
standard deviation of a subgroup over time respectively.  They include the following 
reference lines: the center line, the upper control limit, and the lower control limit (see 
Figures 5-13).  A process may be deemed in control if all the points within its chart fall 
within the region outlined by the UCL and LCL.  Conversely, a process is deemed out of 
control when a sample point falls outside of one of the control limits.
13
   
When a process is out of control, an investigation of possible causes of variability 
should take place.  Numerous causes ought to be considered.  Some sources of error may 
be labor-related, including: changes in operator skill over time, lack of supervision, lack 
of training or inexperience, fatigue, and lack of awareness.  Other potential sources may 
be machine-related, including: rotation of instruments, lack of maintenance, tool damage 
or wear, and the performance of maintenance.  Environmental causes of error may 
include humidity, temperature changes, and other deteriorations of conditions.
17
      
1.7 Benefits and Drawbacks of Control Charts 
 As discussed previously, the strength of control charts lies with their ability to 
detect deviations in a process early.
13
 But beyond their ability to identify process errors 
quickly, Shewhart charts may be applied to a variety of situations with the following 
benefits: ease of calculations, ease of identifying errors in calculations, and the ease of 
identifying sources of process error in trends and patterns.  A chart provides a visual 
11 
representation of the data, being easier to integrate than a simple tabulation.
17
 Control 
charts may also be implemented for the past, present, or future.  For example, control 
charts may be used to evaluate the past.  They may also be used to monitor a process 
while it is in use and provide a real-time sense of its functioning, allowing a potential  
deviation to be identified as it occurs.  Finally, control charts may be applied to the near  
future, predicting future performance based on pre-existing stability and conditions.
16
  
Shewhart charts are not without drawbacks.  First, a Shewhart chart will not solve 
any process control problem on its own, but simply identifies when one may have 
occurred, pointing to a site of investigation.  Further, no Shewhart chart can identify the 
cause of any process deviation, and the process itself must be thoroughly understood to 
look for possible causes. This presents a significant obstacle given that many potential 
identifiable causes may exist.
17
      
1.8 The Central Limit Theorem 
 Shewhart charts assume a normal distribution of data.  As such, the central limit 
theorem is a center-piece for statistical process control, or SPC.  The central limit 
theorem states that as a sample of size n is drawn from a population with the mean µ and 
standard deviation σ, then as n increases, the distribution of the sample means approaches 
a normal distribution.  This approximated normal distribution has a mean of µ and the 
standard error of the means is σ divided by the square root of n.  Thus, even if the 
individual measurements are not normally distributed, the distribution of the means will 
approach a normal distribution as the sample size grows.  As such, the grand mean    is a 
good approximation of the population mean µ.
17
   
12 
 
 
1.9 SPC Control Charts in Other Sciences 
While originating in industry, SPC has become prevalent across many scientific 
fields for its simplicity and broad applicability.  Indeed, Olivares and Lopes support the 
use of control charts as a part of general QA practice in analytical laboratories seeking 
compliance with ISO17025 recommendations.
18
 An example of the wide acceptance of 
statistical process control charts is the field of medicine.  Minne et al have applied control 
charts to provide continuous validation of prognostic models, which are proposed as tools 
for benchmarking, the identification of at-risk patients, and the planning of workloads, 
particularly in intensive care. The authors concluded that statistical process control charts 
show promise as an assessment tool for prognostic tree-models due to their ability to 
detect process drift and instability.
19
   
Other explorations into the application of SPC to medicine are as follows.  
Dupont et al have explored the usefulness of SPC to monitor the improvement of care 
given to women experiencing severe postpartum hemorrhaging.  As the rate of 
postpartum hemorrhaging in developed nations continues to rise, the importance of 
ensuring quality of care against an otherwise highly preventable source of maternal 
mortality is clear.  To this end, the authors have verified the value of SPC as a part of 
their quality improvement program.
20
 Last, Pimentel and Barrueto recommend the use of 
Shewhart charts in emergency department operations due to their ease of use and broad 
13 
utility for process monitoring and improvement, a vital component for ensuring quality 
emergency care.
21
   
Another application for control charts is to assess training processes and learning 
curves.  To this end, Sood et al. investigate the application of SPC to monitor the operator 
learning curve while performing robotic kidney transplantation.  Learning curves, 
traditionally employed in surgical medicine to track operator progress while learning a 
new skill, suffer from the drawbacks of subjective trajectories, a lack of information 
about patient safety, and retrospective assessment.  To overcome these shortcomings, the 
authors applied a combination of cumulative summation and Shewhart control charts, 
concluding that SPC charts permit the prospective assessment of both patient safety and 
operator learning curves and the determination of when a learning curve has ended.
22
    
Beyond medicine, SPC has gained a foothold in many applications of chemistry.  
Multivariate control charts, charts which account for multiple variables simultaneously, 
have been applied to the manufacture of pharmaceuticals.  As explored by Rocha, Rosa, 
Martins, and Poppi, multivariate charts offer simple qualitative identification of correctly 
and incorrectly formulated Nimesulide anti-inflammatory drugs.  Used in supplement 
with near-infrared spectroscopy to measure analyte, residual, and interference signals, 
multivariate charts ensure the correct formulation of this pharmaceutical.
23
  Multivariate 
control charts have also gained recognition as a tool for chemistry-assisted art and 
cultural heritage preservation.  Using multivariate control charts in conjunction with 
infrared spectroscopy to measure analyte degradation, Marengo, Liparota, Robotti, and 
14 
Bobba successfully quantified the oxidation of organic pigments upon exposure to 
ultraviolet radiation over time.
24
   
Within the chemistry laboratory, control charts have gained consideration as a  
cost-saving tool under QA/QC.  Paul and Barnett summarize that control charts, if 
properly applied, can save time and materials through reduced calibration effort.  The 
authors caution that control chart methodologies be designed with care, as data 
correlation in calibration curves may invalidate the control limits of a chart if not 
accounted for.  Further, poorly-selected control charts may lead to additional expended 
time and materials though the investigation of erroneously-assigned deviations.
25
 Others 
have explored the applications of control charts to QC of gas chromatography (GC).  
Nijhuis, de Jong, and Vandeginste compared univariate and multivariate control charts 
for the analysis of fatty acids with GC analysis.  Several univariate charts are needed for 
GC, as it consists of multiple parts in need of process control, including the injector, 
oven, and detector.  They concluded that multivariate charts offered several benefits over 
univariate charts, such as a lower rate of false alarms.  The authors conceded, however, 
that multivariate charts can be difficult to interpret and that univariate charts are better 
suited to investigating and assigning out-of-control events.
26
 
 
15 
2. MATERIALS AND METHODS 
2.1 Data Collection and Shewhart Chart Construction 
Pipette calibration data from the forensic DNA analysis laboratories were 
collected from 2008 to the summer of 2015 at intervals of every six months.  Upon 
receipt, these calibration data were consolidated into Microsoft Excel 2007 (Redmond, 
Washington, USA), in which the subgroup mean for each calibration month for each 
pipette was calculated.  In preparation for the construction of the Shewhart charts, the 
distribution of the subgroup means for one pipette of each size was tested to confirm 
compliance with a normal distribution with the Kolmogorov-Smirnov (KS) test using the 
Tools for Science website.
27
 The p-value for each tested pipette was collected from the 
Tools for Science site as evidence to support the type of distribution.  Once the type 
distribution of the subgroup means for each pipette size was confirmed, the calibration 
data was crafted into a series of    and S charts to analyze the performance of the pipettes 
over this eight year period.   
As the number of sub-measurements n taken during each calibration equaled 10,  
   and S charts were selected to graph the data according to literature recommendations.  
As the calibration data pertained to both the maximum and minimum volume settings for 
each pipette, separate charts were produced for the maximum and minimum settings of 
each.  The grand mean and control limits for the    charts were calculated using equations 
1, 2, and 3.  The grand mean    was calculated as the total mean of each pipette setting’s 
calibration averages collected over each data collection period.  The value of C4 was 
calculated to be 0.9727 when n equals 10 as per equation 4.  The value of k was set at 3 to 
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reflect the industry standard.     was the average of all of the standard deviations 
calculated for each calibration period of that pipette. 
 S charts were calculated to accompany each    chart.  The control limits were 
calculated with equations 5 and 6.  The central line    was calculated as the average of all 
of the standard deviations for the pipette associated with that setting as shown by 
equation 7.  As with the    charts, C4 was calculated to be 0.9727 and k was set to 3.  The 
pipette sizes charted by this method were: 1-10 µL, 1-10 µL multi-channel, 10-100 µL, 
100-1000 µL, 1-3 µL, 30-300 µL, 5-50 µL, 5-50 µL multi-channel, and 500-5000 µL 
pipettes.  A total of 71 pipettes were charted (see Appendix A for a complete list).        
2.2 Inputting ISO8655 Recommended Limits 
Once the basic Shewhart charts for each pipette were completed, additional 
control limits were added.  These additional control limits were calculated from the 
maximum permissible volume error values as recommended by ISO8655 and were added 
to both the    and S charts for every pipette.28 With the ISO limits in place, the Shewhart 
charts were completed and analysis of pipette behavior according to both ISO and 
Shewhart control limits could be performed.    
2.3 Serial Dilution Study to Assess Pipette Volume Delivery Variation 
 To determine whether the volume delivery variations as projected by the 
Shewhart charts could produce any measureable results in casework, a serial dilution 
study was performed.  To this end, a 500 µL ampoule of CF-1 calibration fluid (Thermo 
Scientific, Waltham, Massachusetts, USA), was selected and serially diluted to the 
following ratios: 1:3, 1:9, 1:27, and 1:81.  This aqueous solution of potassium dichromate 
17 
is designed for the calibration of spectrophotometers.
29
  These dilutions were performed 
with the 100-1000 µL pipette J12776B with the following volumes (Table 1): 
Table 1. Liquid volumes for serial dilutions.  All liquid measurements were performed with the 100-1000 
µL pipette J12776B. 
Volume 1:3 Dilution 1:9 Dilution 1:27 Dilution 1:81 Dilution 
DI Water (µL) 850 850 850 850 
CF-1 (µL) 425 (directly 
from ampoule) 
425 (of 1:3 
dilution) 
425 (of 1:9 
dilution) 
425 (of 1:27 
dilution) 
 
These dilution values were selected to account for the limited volume of CF-1 available 
and the ability of the instrument to detect the absorbance of the dilution.  The single 
pipette J12776B was selected to perform all of the serial dilutions for its wide volume 
range and to remove the potential confounding factors of multiple pipette errors 
contributing to the dilution study.      
Once completed, the four serial dilutions would then be measured for their 
absorbance on a NanoDrop 2000/2000c spectrophotometer (Thermo Scientific), with the 
absorbance correlating to the true concentration of the dilution, and thus reflective of any 
variation introduced by volume delivery error.  Both the pedestal and cuvette methods on 
the NanoDrop were selected for testing and in a replicate of 10 for each dilution.  Prior to 
the dilution study, a number of preparatory steps were performed with the NanoDrop.  
First, the NanoDrop pedestal was cleaned with 10% bleach solution in DI water on a 
clean Kimwipe and wiped again with DI water to remove any bleach residue.  The 
cuvette region was cleaned with a dry Kimwipe, ensuring that no liquid entered the 
cuvette slot.  Once cleaned, an intensity check was performed with the pedestal arm 
lowered.  The intensity check was followed by a blanking cycle with 2 µL of DI water to 
ensure that the pedestal measurement varied by no more than 0.04 A at a path length of 
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1.0 cm.  Then, the NanoDrop was calibrated with undiluted CF-1 fluid using the target 
absorbance listed on the ampoule packaging.  All of above preparatory steps were 
performed in accordance with the manufacturer’s instructions.30,31    
For the pedestal method, 2 µL of deionized (DI) water was dispensed as a blank 
with a 10 µL pipette.  After the blank was read, it was wiped off with a clean Kimwipe 
and a fresh aliquot of 2 µL of the diluted CF-1 solution was administered for each 
measurement, for a total of 10.  The previous aliquot was removed with a clean Kimwipe 
each time.   This process was repeated for each of the four serial dilutions.  Additionally, 
the excess undiluted CF-1 liquid was measured with the pedestal method to the same 
specifications as the 4 serial dilutions.  
For the cuvette method, 800 µL of DI water was measured as a blank in a clear, 
plastic cuvette.  Once the NanoDrop was blanked with DI water, 800 µL of each of the 
four dilutions was measured in a separate but similar clear plastic cuvette for a total of 10 
measurements each.  Undiluted CF-1 liquid was not measured by this method due to a 
lack of sufficient remaining fluid.  Once the measurements were completed, all of the 
spectra were exported into Excel for analysis.    F-tests were performed in Excel using the 
pedestal absorbance data at 350 nm to determine the equality of variances between the 
undiluted and the diluted CF-1 solutions, with an alpha-level set to 0.05.     
2.4 Stella Simulations of Pipette Volume Delivery 
 Once the measurements of the dilutions on the NanoDrop were completed, it 
became necessary to determine a standard of comparison.  It would not be possible to 
correlate experimental absorbance values skewed by pipetting error, as obtained from the 
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NanoDrop, without some standard of what the absorbance values of a perfect serial 
dilution would be.  To accomplish this, a pre-built model in Stella v10.0.2 (isee systems, 
Lebanon, New Hampshire, USA), a dynamic modeling program, was implemented to 
simulate the outcomes of an experimental series of four dilutions under a number of 
definable conditions over a total of 1000 trials.  Attached below are images of the Stella 
model interface (Figures 1-4): 
 
Figure 1. Image of Stella v10.0.2 model interface control panel.  Displayed are the entry slots for the 
testable variables, including: the starting concentration of the standard (Initial Std Conc.), the set volumes 
for the buffer and standard (Set Volume Buffer/Std), the volumetric bias of the pipette for the buffer and 
standard (Bias of Set Volume Buffer/Std), and the standard deviation of the pipette for the buffer and 
standard (Stdev for Volume Buffer/Std).  Also included are the entry slots for the molar absorptivity and 
the path length, so to simulate the absorbance of any solution.   
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Figure 2. Image of Stella v10.0.2 model output table 1.  Displayed is the output table for the 
concentrations calculated from the values entered into the control panel.   
 
 
Figure 3. Image of Stella v10.0.2 model output table 2.  Displayed is the output table for the volumes 
calculated from the values entered into the control panel.   
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Figure 4. Image of Stella v10.0.2 model output table 3.  Displayed is the output table for the absorbances 
calculated from the values entered into the control panel.   
 
Before any absorbance simulations could be performed, it was necessary to select 
a molar absorptivity and target wavelength as well as calculate the starting concentration 
of the CF-1 fluid.  The wavelength 350 nm and its corresponding molar absorptivity of 
10.73 kg/gcm
-1 
were selected based on literature recommendations.
32,33
  Using this molar 
absorptivity, the initial concentration of the CF-1 solution was calculated.  With the 
starting concentration known, a series of simulations for comparison with the 
experimental absorbance data was performed.   
First, a pair of unbiased control simulations was performed for comparison to the 
pedestal and the cuvette method, to establish what the absorbance values ought to be in 
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the absence of pipette variability.  That is, the volume bias and standard deviations of the 
pipette J12776B were set to zero to simulate perfect and unchanging volume delivery.  
The values in the simulations were set to match those of the serial dilution: 850 µL of 
buffer, 425 µL of standard solution, the calculated initial concentration of the CF-1, and 
the selected molar absorptivity.  Additionally, the path length was set to match that of the 
method being duplicated by the simulation.  The resultant concentrations, volumes, and 
absorbance values were exported into Excel 2007 for analysis.   
A second pair of simulations for the absorbance data was produced, this time 
incorporating some pipette error.  Because the bias and standard deviations for the 
volume settings on J12776B (850 µL and 425 µL) were not known, the standard 
deviation for these volumes was instead estimated from the percent standard deviation of 
pipette J12776B’s most recent calibration data (September 2015).  To accomplish this, 
the percent standard deviation of J12776B’s maximum volume setting (1000 µL) was 
calculated, and this percent standard deviation was multiplied by the volumes used in the 
simulation (850 µL and 425 µL) to yield projected standard deviations for these 
intermediate volumes.   Volumetric bias was left at zero. The decision was made to set 
the volumetric bias to zero, rather than calculate a percent estimate as was done with the 
standard deviations, because the volumetric biases from J12776B’s most recent 
calibration data were not internally consistent across the maximum and minimum volume 
settings.  That is, the maximum volume setting’s average was below the nominal volume 
while the minimum volume setting’s average was above the nominal volume.  As such, 
the volumetric biases for the intermediary volumes used could not be reliably estimated  
23 
from the extremities. 
  Tables 2 and 3 display the estimated volumetric bias and standard deviation  
values used in the simulations and the original calibration data from which these 
estimates were calculated: 
Table 2. Estimated volumetric bias and standard deviations for pipette J12776B at nonstandard 
volumes.  The standard deviations for these volumes are calculated for these volumes using the percent 
standard deviations of J12776B’s most recent calibration at the volumes 100 and 1000 µL.   
Volume Setting (µL) Estimated Volumetric 
Bias (µL) 
Estimated Standard 
Deviation 
850 0 1.66 
425 0 0.83 
 
Table 3. Latest calibration data for pipette J12776B.  Displayed are the calibration data and calculated 
bias values for pipette J12776B during its latest calibration in September 2015. 
Volume Setting 
(µL) 
Mean  (µL) Volumetric 
Bias (µL) 
Standard 
Deviation 
Percent Standard 
Deviation (%) 
100 104.03 4.03 0.53 0.509 
1000 993.73 -6.27 1.953 0.197 
 
With these projected standard deviations, this second pair of simulations was collected 
with settings and values identical to the unbiased pair described above, but this time 
including the calculated standard deviations.  The resultant concentrations, volumes, and 
absorbance values were also exported for analysis.   
2.4.1 Additional Stella Volume Delivery Simulations  
 Additional Stella simulations were performed separate from the absorbance data  
simulations.  These additional simulations were solely concerned with volume delivery as 
it relates to whether the pipette was in or out of control by the standards of ISO8655 and 
the Shewhart charts, and thus no absorbance data were collected for these simulations.  
Pipette J12776B was selected due to its previous use in the serial dilution study and a 
total of five simulations for this pipette were collected using the following conditions: no 
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bias (no standard deviation or volumetric bias), in Shewhart and ISO control, out of 
Shewhart but in ISO control, out of both Shewhart and ISO control, and the most recent  
calibration (September 2015).   
To acquire these values, past calibration data points were selected from 
J12776B’s charts in accordance with the parameters being tested.  Rather than follow the 
1:3 dilution pattern being used in the serial dilution absorbance study, a 1:11 serial 
dilution pattern was selected to reflect the lower and upper volume limits of the pipette 
(100 µL and 1000 µL respectively).  The standard solution volume was set to 100 and the 
buffer volume was set to 1000.  The molar absorptivity and path length were left empty 
due to a lack of need for absorbance data.  The volumetric bias and standard deviation 
values entered in these simulations are tabulated in Table 4: 
Table 4. Simulation entry values for pipette J12776B in various states of control.  Listed are the bias 
and standard deviation values entered for J12776B for its maximum and minimum volume settings of 100 
and 1000 µL. 
Simulated 
Conditions 
Volumetric 
Bias of 
Minimum 
Volume (µL) 
Standard 
Deviation of 
Minimum 
Volume 
Volumetric 
Bias of 
Maximum 
Volume (µL) 
Standard 
Deviation of 
Maximum 
Volume 
Perfect control (no 
bias) 
0 0 0 0 
In Shewhart and 
ISO Control 
0.022 2.377 0.339 1.091 
Out of Shewhart 
and in ISO 
Control 
6.178 2.112 1.908 0.859 
Out of Shewhart 
and ISO Control 
-7.525 3.410 -4.59 4.421 
Most Recent 
Calibration 
-6.27 1.953 4.030 0.53 
 
The resultant concentrations and volumes were exported for exploratory data analysis.   
Last, a set of two-pipette simulations was performed to explore the possible  
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impact of using multiple pipettes to perform a serial dilution, as would be typical in 
general laboratory work.  The two pipettes selected were the 1-10 µL pipette CH32371 
and the 100-1000 µL pipette CH80353, with the standard solution volume set to 10 and 
the buffer volume set to 1000 in the simulation.  This series tested a similar set of 
conditions for the two pipettes: no bias (no standard deviation or volumetric bias), in 
Shewhart and ISO control, out of Shewhart but in ISO control, out of both Shewhart and 
ISO control.  As before, calibration points from these pipettes’ charts were selected to 
fulfill these conditions.  Also as before, no absorbance data was produced and thus the 
path length and molar absorptivity were left blank.  The volumetric bias and standard  
deviation values entered in these simulations are tabulated in Table 5: 
 
Table 5. Simulation entry values for pipettes CH32371 and CH80353 in various states of control.  
Listed are the bias and standard deviation values entered for pipettes CH32371, set to 10 µL, and CH80353, 
set to 1000 µL. 
Simulated 
Conditions 
Volumetric 
Bias of 
CH32371  
(µL) 
Standard 
Deviation of 
CH32371 
Volumetric 
Bias of 
CH80353  
(µL) 
Standard 
Deviation of 
CH80353 
Perfect control (no 
bias) 
0 0 0 0 
In Shewhart and 
ISO Control 
0.014 0.063 -2.069 2.164 
Out of Shewhart 
and in ISO 
Control 
-0.108 0.071 -4.525 1.193 
Out of Shewhart 
and ISO Control 
0.136 0 -4.59 4.521 
 
Once completed, the resultant concentrations and volumes were exported for 
visualization.    
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3. RESULTS AND DISCUSSION 
3.1 Confirmation of a Normal Distribution 
 The distribution of the means for one pipette of each size was tested against a 
normal distribution with the KS test.  The p-values for the minimum and maximum 
volume settings for each pipette are tabulated below (Table 6): 
Table 6.  Calculated p-values and distribution for the pipettes’ maximum and minimum volume 
settings with the KS test. The calculated p-values for all of the pipettes sizes successfully tested confirm 
that the distributions for their subgroups averages are consistent with a normal distribution in agreement 
with the Central Limit Theorem 
Pipette Serial Number, 
Size 
Calculated p-
value for 
minimum volume 
Calculated p-
value for 
maximum volume 
Consistent with a 
normal 
distribution 
CH66867, 1-10 µL 
DH10303, 10-100 µL 
0.81 
0.85 
0.93 
0.87 
yes 
yes  
CH80348, 100-1000 µL 
CJ20298, 1-3 µL 
0.49 
0.84 
0.41 
0.99 
yes 
yes 
CH88175, 30-300 µL 
CH63131, 5-50 µL 
0.52 
0.35 
0.79 
0.77 
yes 
yes 
DH49860, 500-5000 µL 0.35 0.77 yes 
 
As shown in Table 6, the p-values and distribution feedback, as given by the KS test on 
the Tools for Science website, support that the distributions of the pipettes tested are 
consistent with a normal distribution.  This demonstrates that the pipette calibration data 
are consistent with the outcome predicted by the Central Limit Theorem and thus are 
suitable for analysis with a series of    and S charts.  The pipettes that were excluded from 
this analysis were the 1-10 µL and 5-50 µL multi-channel pipettes, as none of the pipettes 
within those sets had a sufficient number of data points to perform a KS test by this 
method.  Given the tested pipettes consistently supported a normal distribution, it was 
instead assumed that all other pipettes of that size as well as the multi-channel pipettes 
also followed a normal distribution. 
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3.2 Comparison of the    and S Charts with ISO8655  
 With normality confirmed, the    and S charts were produced for each pipette and 
the ISO8655 recommended limits inserted.  A representative collection is provided, 
showcasing the charts for the maximum and minimum volume settings for a single 
pipette of each size (Figures 5-13): 
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Figure 5.    and S charts for the 1-10 µL pipette CH84435.  The top left is the   chart for the minimum 
volume and at the top right is its corresponding S chart.  The bottom left is the   chart for the maximum 
volume and the bottom right is its corresponding S chart.  The x-axis displays the month followed by the 
year the calibration was performed.  The y-axis displays the pipette delivery volume in microliters.  The 
black points represent the individual average volumes measured upon each calibration.  The upper and 
lower solid grey lines represent the upper and lower control Shewhart limits and the dashed grey line 
represents the grand mean.  The bolded, solid black lines represent the ISO8655 recommended limits and 
the dashed, bolded black line represents the nominal volume the pipette is supposed to deliver at that 
setting. 
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Figure 6.    and S charts for the 1-10 µL multi-channel pipette CH54605.  The top left is the   chart 
chart for the minimum volume and at the top right is its corresponding S chart.  The bottom left is the 
  chart for the maximum volume and the bottom right is its corresponding S chart.  The x-axis displays the 
month followed by the year the calibration was performed.  The y-axis displays the pipette delivery volume 
in microliters.  The black points represent the individual average volumes measured upon each calibration.  
The upper and lower solid grey lines represent the upper and lower control Shewhart limits and the dashed 
grey line represents the grand mean.  The bolded, solid black lines represent the ISO8655 recommended 
limits and the dashed, bolded black line represents the nominal volume the pipette is supposed to deliver at 
that setting. 
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Figure 7.   and S charts for the 10-100 µL pipette CH68041.  The top left is the   chart for the 
minimum volume and at the top right is its corresponding S chart.  The bottom left is the   chart for the 
maximum volume and the bottom right is its corresponding S chart.  The x-axis displays the month 
followed by the year the calibration was performed.  The y-axis displays the pipette delivery volume in 
microliters.  The black points represent the individual average volumes measured upon each calibration.  
The upper and lower solid grey lines represent the upper and lower control Shewhart limits and the dashed 
grey line represents the grand mean.  The bolded, solid black lines represent the ISO8655 recommended 
limits and the dashed, bolded black line represents the nominal volume the pipette is supposed to deliver at 
that setting. 
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Figure 8.    and S charts for the 100-1000 µL pipette CH80833.  The top left is the   chart for the 
minimum volume and at the top right is its corresponding S chart.  The bottom left is the   chart for the 
maximum volume and the bottom right is its corresponding S chart.  The x-axis displays the month 
followed by the year the calibration was performed.  The y-axis displays the pipette delivery volume in 
microliters.  The black points represent the individual average volumes measured upon each calibration.  
The upper and lower solid grey lines represent the upper and lower control Shewhart limits and the dashed 
grey line represents the grand mean.  The bolded, solid black lines represent the ISO8655 recommended 
limits and the dashed, bolded black line represents the nominal volume the pipette is supposed to deliver at 
that setting. 
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Figure 9.    and S charts for the 1-3 µL pipette CJ20298.  The top left is the   chart for the minimum 
volume and at the top right is its corresponding S chart.  The bottom left is the   chart for the maximum 
volume and the bottom right is its corresponding S chart.  The x-axis displays the month followed by the 
year the calibration was performed.  The y-axis displays the pipette delivery volume in microliters.  The 
black points represent the individual average volumes measured upon each calibration.  The upper and 
lower solid grey lines represent the upper and lower control Shewhart limits and the dashed grey line 
represents the grand mean.  The bolded, solid black lines represent the ISO8655 recommended limits and 
the dashed, bolded black line represents the nominal volume the pipette is supposed to deliver at that 
setting. 
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Figure 10.    and S charts for the 30-300 µL pipette CH66488.  The top left is the   chart for the 
minimum volume and at the top right is its corresponding S chart.  The bottom left is the   chart for the 
maximum volume and the bottom right is its corresponding S chart.  The x-axis displays the month 
followed by the year the calibration was performed.  The y-axis displays the pipette delivery volume in 
microliters.  The black points represent the individual average volumes measured upon each calibration.  
The upper and lower solid grey lines represent the upper and lower control Shewhart limits and the dashed 
grey line represents the grand mean.  The bolded, solid black lines represent the ISO8655 recommended 
limits and the dashed, bolded black line represents the nominal volume the pipette is supposed to deliver at 
that setting. 
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Figure 11.    and S charts for the 5-50 µL pipette CH57869.  The top left is the   chart for the minimum 
volume and at the top right is its corresponding S chart.  The bottom left is the   chart for the maximum 
volume and the bottom right is its corresponding S chart.  The x-axis displays the month followed by the 
year the calibration was performed.  The y-axis displays the pipette delivery volume in microliters.  The 
black points represent the individual average volumes measured upon each calibration.  The upper and 
lower solid grey lines represent the upper and lower control Shewhart limits and the dashed grey line 
represents the grand mean.  The bolded, solid black lines represent the ISO8655 recommended limits and 
the dashed, bolded black line represents the nominal volume the pipette is supposed to deliver at that 
setting. 
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Figure 12.    and S charts for the 5-50 µL multi-channel pipette CH54595.  The top left is the   chart 
for the minimum volume and at the top right is its corresponding S chart.  The bottom left is the   chart for 
the maximum volume and the bottom right is its corresponding S chart.  The x-axis displays the month 
followed by the year the calibration was performed.  The y-axis displays the pipette delivery volume in 
microliters.  The black points represent the individual average volumes measured upon each calibration.  
The upper and lower solid grey lines represent the upper and lower control Shewhart limits and the dashed 
grey line represents the grand mean.  The bolded, solid black lines represent the ISO8655 recommended 
limits and the dashed, bolded black line represents the nominal volume the pipette is supposed to deliver at 
that setting. 
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Figure 13.    and S charts for the 500-5000 µL pipette DH49862.  The top left is the   chart for the 
minimum volume and at the top right is its corresponding S chart.  The bottom left is the   chart for the 
maximum volume and the bottom right is its corresponding S chart.  The x-axis displays the month 
followed by the year the calibration was performed.  The y-axis displays the pipette delivery volume in 
microliters.  The black points represent the individual average volumes measured upon each calibration.  
The upper and lower solid grey lines represent the upper and lower control Shewhart limits and the dashed 
grey line represents the grand mean.  The bolded, solid black lines represent the ISO8655 recommended 
limits and the dashed, bolded black line represents the nominal volume the pipette is supposed to deliver at 
that setting. 
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recommended limits, corroborating the usefulness of ISO8655 control limits as a basic 
standard for pipettes.  Notably, the Shewhart control limits are universally much tighter 
for the    charts than their corresponding ISO control limits.  That most of the pipettes are 
out-of-control according to the Shewhart limits is not necessarily meaningful on its own. 
Rather, the purpose of the Shewhart charts is to elucidate any trends that the pipettes may 
demonstrate or any errors associated with the calibration process itself.   
3.2.1 Comparison of the Grand Mean and Nominal Volume 
Also notable is how the grand mean for the    chart relates to the nominal volume 
for each pipette.  For most of the pipettes shown, including the 1-10 µL pipette CH84435 
(Figure 5), 1-10 µL multi-channel pipette CH54605 (Figure 6), 10-100 µL pipette 
CH68041 (Figure 7), 1-3 µL pipette CJ20298 (Figure 9), 5-50 µL pipette CH57869 
(Figure 11), and 5-50 µL multi-channel pipette CH54595 (Figure 12), the grand means 
closely agree with the nominal volume.  This suggests that pipette performance generally 
fluctuates about the nominal volume.   
In contrast, the grand means for the following pipettes are skewed noticeably 
higher than the nominal volume: 100-1000 µL pipette CH80833 (Figure 8), 30-300 µL 
pipette CH66488 (Figure 10), and 500-5000 µL pipette DH49862 (Figure 13).  This trend 
indicates possible systematic bias, although this trend is confined to the minimum volume 
settings for these pipettes.  Further, most of the pipettes, are skewed above the nominal 
volume, even if only slightly.  Some of the pipettes have grand means skewed below the 
nominal volume, including 1-10 µL multi-channel pipette CH54605 (Figure 6), 100-1000 
µL pipette CH80833 (Figure 8), 1-3 µL pipette CJ20298 (Figure 9), and 500-5000 µL 
38 
pipette DH49862 (Figure 13).  For these pipettes, the low-skewed grand means are 
exclusively for the maximum volume settings.  The sole exception is the multi-channel 
pipette CH54605 (Figure 6), whose grand mean is skewed low for the minimum volume 
setting.  These trends indicate the usefulness of Shewhart charts to monitor for systematic 
bias in pipettes over time.   
3.2.2 On the Value of an LCL for Calibration Standard Deviations 
Also important is the addition of an LCL for the S charts.  ISO8655 
recommendations alone only provide a maximum allowable standard deviation, and no 
lower control limit.  The addition of a lower Shewhart limit provides an essential addition 
that ISO8655 alone cannot provide.  By adding a lower control limit, it is simple to 
identify calibration data with a standard deviation near or at zero, a value which is 
improbable given the inevitability of variation in pipette volume delivery and a potential 
sign of incorrect calibration or operator error.  Indeed, calibration data with standard 
deviations of zero were identified by this method in the raw calibration data and had to be 
excised from the final charts.   That a pipette with a standard deviation of zero, which 
indicates a serious error in operator or pipette performance, could still pass ISO8655 
calibration standards serve as evidence that a lower control limit is needed for pipette 
standard deviation calibration.  An example S chart is shown to demonstrate this (Figure 
14): 
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Figure 14. S charts for pipette CH50671 displaying a standard deviation of 0.  To the left is the S chart 
for the minimum volume setting for the 1-10 µL pipette CH50671.  To the right is the S chart for the 
maximum volume setting for the same pipette.  Note that the measured standard deviation for the 
calibration month February of 2011 shows a standard deviation of 0 for both the maximum and minimum 
volume settings, indicating a likelihood of pipette malfunction or operator error.   
 
As shown by Figure 14, Shewhart charts are well suited for identifying calibration 
points, particularly standard deviations, which deviate from expected values and 
conditions.  In this case, an investigation for possible malfunctions with the pipette itself 
and the operator’s skill level ought to be initiated.  However, many of the UCL for the S- 
charts exceed the ISO8655 recommendations.  Thus, any Shewhart UCL that exceeds the 
ISO8655 threshold would be out of compliance and should not be considered if ISO 
accreditation is sought.  The reason that most of the S chart UCL threshold exceeds the 
ISO8655 limits is likely due to the fact that the value of    is set very close to the ISO8655 
limit, forcing the UCL higher than is desirable.  Nonetheless, the presence of a point that 
exceeds the UCL calculated by the Shewhart method may still illuminate a process 
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40 
control problem and provide valuable information beyond what the ISO upper control 
limit alone can offer. 
3.3 Serial Dilution Absorbance Data Collection 
A series of 4 serial dilutions from 1:3 to 1:81 was performed with CF-1 using the 
100-1000 µL pipette J12776B.  These dilutions were measured on a NanoDrop using 
both the cuvette and pedestal methods.  The full absorbance spectra are displayed below 
(Figures 15 and 16): 
 
Figure 15. Full absorbance spectra for CF-1 by the pedestal method.  Collected are the full absorbance 
spectra taken for the 4 serial dilutions in addition to the spectrum of the undiluted CF-1 fluid.  The largest 
spectrum, shown in black, corresponds with the undiluted CF-1solution. The progressively smaller spectra 
correspond with the progressively increasing dilutions from 1:3 down to 1:81 and are shaded from dark to 
light grey.  All measurements taken with the pedestal method on the NanoDrop. 
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Figure 16. Full absorbance spectra for CF-1 by the cuvette method.  Collected are the full absorbance 
spectra taken for the 4 serial dilutions.  The largest spectrum corresponds with the 1:3 dilution and is 
shaded dark grey.  The progressively smaller spectra correspond with the progressively increasing dilutions 
from 1:9 down to 1:81 and are shaded from dark to light grey.  The spectrum for undiluted CF-1 was not 
measured by cuvette and is thus not included in this chart.  All measurements taken with the cuvette 
method on the NanoDrop. 
 
The absorbance spectra are shown to be consistent between the pedestal and cuvette 
methods, supporting that both methods are comparable.  The high level of noise for the 
1:3 dilutions shown between 220nm and 310nm in Figure 16 suggests that a wavelength 
after 310nm ought to be selected for better spectral stability.   
3.4 Examination of the Serial Dilution Absorbance Data with the F-test 
 An F-test was performed in Excel to clarify whether the variances of the four 
serial dilution absorbance values all matched that of the undiluted CF-1 fluid.  The results 
are displayed below (Table 7): 
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Table 7.  F-Test results for the pedestal absorbance data across the 4 serial dilutions.   Results of the 
F-test for two-sample variance as performed in Excel 2007.  The variance of each of the 4 dilutions was 
tested against the variance of the undiluted CF-1 solution, with the resultant p-values displayed.  
Significance level alpha of 0.05.  The average, standard deviation, and percent standard deviation for each 
solution are also shown.  All measurements taken on the NanoDrop pedestal. 
CF-1 
Dilution  
Average 
(A) 
Standard 
Deviation 
Percent Standard 
Deviation (%) 
Variance p-Value 
Undiluted 0.7516 0.00648 0.863 4.20×10
-5 
N/A 
1:3 Dilution 0.2509 0.00099 0.396 9.88×10
-7 
2.62×10
-6 
1:9 Dilution 0.0847 0.00095 1.120 9.00×10
-7 
1.74×10
-6
 
1:27 Dilution 0.0278 0.00103 3.715 1.07×10
-6 
3.63×10
-6
 
1:81 Dilution 0.0124 0.00084 6.800 7.11×10
-7 
6.23×10
-7
 
 
The p-values for each of the four serial dilutions is smaller than the alpha value of 0.05, 
indicating that the variances between the four dilutions and the undiluted CF-1 solution 
are not equal.  However, there is no significant change in the variance across the dilutions 
though the absorbance decreased by a factor of 10.  Further, the percent standard 
deviation also consistently increases for each solution, demonstrating that the standard 
deviation, and thus the precision, for the absorbance does not significantly change with 
the concentration of the solution. 
3.5 Selection of a Wavelength and Molar Absorptivity 
 In order to interpret the absorbance values obtained from the dilution study for 
signs of pipetting error, it was necessary to perform simulations with Stella in order to 
approximate how the pipette J12776B would be expected to behave under a variety of 
circumstances.  Multiple wavelengths and their corresponding molar absorptivities,  
published by Gil et al. and Burke et al., were considered for use.
32,33
  The wavelengths 
and their respective molar absorptivities are tabulated (Table 8): 
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Table 8. Published wavelengths and molar absorptivities.  Shown below are the published molar 
absorptivities for the four wavelengths 235, 257, 313, and 350nm.   
a
 Mean obtained from the molar absorptivities published by Gil et al.32  
b Mean calculated from the molar absorptivities varying across concentration published by Burke et al.33 
Wavelength 
(nm) 
Mean Molar Absorptivity 
(L/(mol×cm))
a 
Mean Molar Absorptivity 
(kg/(g×cm))
b 
235 1829.9 12.49 
257 2124.0 14.56 
313 714.9 4.83 
350 1579.4 10.73 
 
The molar absorptivities published by Burke et al. were averaged to produce a single 
usable value for entry into the Stella interface.
33
  Uncertainty for the molar absorptivity 
was excluded from this study as the simulation did not have an entry table to 
accommodate such error.   
These wavelengths, which correspond to the peaks and troughs of potassium 
dichromate’s UV/Vis absorbance spectrum, provide the best spectral stability for 
calibration purposes (Figures 15 and 16).  But, as potassium dichromate breaks down into 
both hydrogen chromate and dichromate, with hydrogen chromate being the dominant 
species, the spectral overlap between the 2 species cannot be readily resolved.  As the 
concentration of potassium dichromate increases, its molar absorptivity also increases as 
the speciation of the solution changes.
33 
It is for this reason that the wavelengths of the 
peaks and troughs were chosen.  The wavelength 350 nm was described as the best 
overall wavelength for absorbance measurement, as it offers a decent degree of linearity 
across concentrations.
32
 Other factors that would influence the absorbance, such as 
solution temperature, were controlled by performing all of the dilutions and 
measurements in one session to offset the effects on inter-day laboratory temperature 
variations.  Further, the dilutions and measurements were performed within one hour of 
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initially opening the ampoule, as recommended by the manufacturer, to reduce the risk 
concentration alteration through environmental exposure.
30
 
With this established, the wavelength 350 nm was selected for its stability and 
linearity and its corresponding average molar absorptivity 10.730 kg/(g×cm) was selected 
to calculate the starting concentration of the CF-1 for convenience with the Stella model.  
With this molar absorptivity, the starting concentration was calculated to be 0.700 g/kg 
from the absorbance data taken of the undiluted CF-1 fluid on the pedestal.      
3.6 Comparison of the Dilution Study and Stella Modeling Results for J12776B 
3.6.1 Pedestal and Stella Simulation Data Comparison 
 With the starting concentration and molar absorptivity acquired, a series of 
simulations were performed in Stella and graphed in Excel for comparison to the 
experimental data.  The resultant charts compare the outcomes of the dilution study and 
the Stella simulations with the following settings: with volumetric bias and standard 
deviation set to zero and with volumetric bias set to zero with a standard deviation 
estimated from the most recent calibration data.  The results are shown below (Figure 
17): 
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Figure 17.  Comparison of Pedestal Absorbance Data with Stella Simulations for J12776B.  Starting in 
the top left and progressing to the bottom right are the absorbance values for the 4 serial dilutions 1:3, 1:9, 
1:27, and 1:81.  The darkest grey bar shows the absorbance values collected experimentally on the pedestal.  
The middle grey bar shows the absorbance values calculated in Stella for when the volumetric bias and 
standard deviation are 0.  The lightest grey bar shows the absorbance values calculated in Stella for when 
the volumetric bias is 0 and standard deviation is estimated from percent standard deviation of J12776B’s 
most recent calibration.  The standard deviations for each bar are displayed to show the variation and 
overlap of each. 
 
No statistically significant differences can be observed between the experimental 
absorbance data and the Stella simulations for the dilutions 1:3, 1:9, and 1:27.  The sole 
exception is the 1:81 dilution, which demonstrates that the absorbance’s collected on the 
pedestal are higher than those of the simulations.  This indicates possible pipette volume 
delivery error of a margin great enough to introduce significant bias downstream, but this 
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trend is not corroborated by the other data and thus it is unclear whether this is a sign of 
systematic pipette bias.  Also noteworthy is that the standard deviations of the two 
simulation sets are almost identical, hinting that a standard deviation alone that was 
within ISO limits, without volumetric bias, was not a significant source of pipetting error. 
3.6.2 Cuvette and Stella Simulation Data Comparison 
The comparison charts for the cuvette absorbance data acquired and the Stella 
simulations are shown (Figure 18): 
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Figure 18.  Comparison of Cuvette Absorbance Data with Stella Simulations for J12776B.  Starting in 
the top left and progressing to the bottom right are the absorbance values for the 4 serial dilutions 1:3, 1:9, 
1:27, and 1:81.  The darkest grey bar shows the absorbance values collected experimentally on the pedestal.  
The middle grey bar shows the absorbance values calculated in Stella for when the volumetric bias and 
standard deviation are 0.  The lightest grey bar shows the absorbance values calculated in Stella for when 
the volumetric bias is 0 and standard deviation is estimated from percent standard deviation of J12776B’s 
most recent calibration.  The standard deviations for each bar are displayed to show the variation and  
overlap of each. 
 
In contrast to the pedestal method, the dilutions 1:3, 1:9, and 1:27 are consistently 
significantly different and lower than the simulation data.  The sole exception is the 1:81 
dilution, which demonstrates complete overlap with the simulation data.  As with the 
simulations for the pedestal, the standard deviations for the simulation sets are also 
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deviation is solely dictated by the absorbance data, not including pipetting error, is the 
smaller of the two sets.  The trend visualized by the pedestal data is inverted with the 
cuvette, in which the first three dilutions show signs of significant pipette bias and the 
final dilution does not, despite being measurements of the same solution.  Whether this 
trend inversion is the result of instrumental differences between the two methods or not is 
unknown and has not been investigated. 
3.7 Comparison of J12776B Simulations in Relation with Shewhart Charts 
 To further explore the potential ramifications of pipetting bias under a variety of 
circumstances, a second series of simulations were performed.  These simulations, 
making use of calibration data for pipette J12776B, elucidate the projected impact of how 
its state of control affects its performance in a sequence of four 1:11 serial dilutions.  The 
simulations explore the following: when the pipette demonstrates no error, when the 
pipette is in control relative to both the Shewhart and ISO control limits, when it is within 
ISO control but out of Shewhart control, out of both Shewhart and ISO control, and what 
its most recent calibration data indicate. The charts are shown below (Figure 19): 
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Figure 19.  J12776B performance in relation to various levels of control. Starting in the top left and 
progressing to the bottom right are the simulated concentrations for the 4 serial dilutions 1:3, 1:9, 1:27, and 
1:81.   The dark grey bar on the farthest left shows the concentration value for when the volumetric bias 
and standard deviation are 0.  The grey bar second from the left shows the calculated concentration for 
when J12776B is in control with both the Shewhart and ISO limits.  The grey bar in the center shows the 
calculated concentration when J12776B is out of Shewhart control but within ISO control.  The grey bar 
second to the right shows the calculated concentration when J12776B is out of Shewhart and ISO control.  
Last, the light grey bar to the farthest right shows the calculated concentration for J21776B’s most recent 
calibration.  The standard deviations for each bar are displayed to show the variation and overlap of each. 
 
 As shown above in Figure 19, only when J12776B is in a state of statistical 
control relative to both its Shewhart chart and ISO does its simulated concentration 
overlap with the nominal concentration for when no pipetting error occurs.  This holds 
true across all four serial dilutions and indicates that even in the presence of minor 
volumetric bias, a pipette that is strongly in both Shewhart and ISO control will emulate 
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the nominal volume.  The remaining two circumstances, expressing a lack of control 
relative to Shewhart or both Shewhart and ISO, demonstrate a profound lack of 
agreement with the nominal volume.  This posits that pipette J12776B, whether only just 
in control or completely out of control with ISO, would introduce noticeable systematic 
bias completely in disagreement with the nominal volume setting being used.  Last, the 
examination of J12776B’s most recent calibration using the simulation indicates that the 
most recent calibration data introduces systematic bias on par with being out of control 
with Shewhart and in control with ISO, a finding corroborated by the comparison of this 
most recent calibration with J12776B’s Shewhart charts.  The findings of the last three 
conditions all justify the need for robust control over pipette delivery variation, as any 
labor performed under those conditions would introduce significant error.  Table 9 
presents a summary of the percent errors of each of the 4 conditions relative to the error-
free value across all four dilutions:       
Table 9. Summary of percent errors for pipette J12776B across various states of control.  Displayed 
are the percent errors of the calculated average concentrations of the 4 dilutions across various states of 
control with pipette J12776B. 
Dilution In Shewhart 
and ISO 
Control (%) 
Out of Shewhart 
and in ISO 
Control (%) 
Out of Shewhart 
and ISO Control 
(%) 
Most Recent 
Calibration 
(%) 
1
st
 Dilution 0.046 5.593 6.432 4.240 
2
nd
 Dilution 0.043 11.233 12.599 8.659 
3
rd
 Dilution 0.012 17.134 18.251 13.249 
4
th
 Dilution 0.086 23.33 23.538 18.075 
 
As these values demonstrate, it is possible to accumulate significant error across a serial 
dilution even when within ISO control alone, reinforcing the value for Shewhart control 
methods as a supplementary monitoring tool.  
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3.8 Simulation of a Two-Pipette Dilution Series 
 As most dilutions performed in a laboratory make use of multiple pipettes, it 
became necessary to explore how the biases of multiple pipettes might impact a serial 
dilution.  To this end, a series of simulations was performed using calibration data from 
the 1-10 µL pipette CH32371 and the 100-1000 µL pipette CH80353.  As with the 
simulation study on J12776B, calibration data for each pipette was selected for testing the 
following scenarios: no systematic bias for either pipette, when both pipettes are in 
Shewhart and ISO control, when both pipettes are out of Shewhart but in ISO control, 
and when both pipettes are out of both Shewhart and ISO control.  The results are shown 
below (Figure 20): 
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Figure 20.  Two-pipette dilution performance in relation to various levels of control. Starting in the top 
left and progressing to the bottom right are the simulated concentrations for the 4 serial dilutions produced 
by the 1-10 µL pipette CH32371 and the 100-1000 µL pipette CH80353.  The dark grey bar on the farthest 
left shows the concentration value for when the volumetric bias and standard deviation are 0.  The grey bar 
second from the left shows the calculated concentration for when the pipettes are both in control with the 
Shewhart and ISO limits.  The grey bar second to the tight shows the calculated concentration when both 
pipettes are out of Shewhart control but within ISO control.  The grey bar farthest to the right shows the 
calculated concentration both pipettes are out of Shewhart and ISO control.  The standard deviations for 
each bar are displayed to show the variation and overlap of each. 
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Shewhart and ISO control, the solution shows no overlap with the nominal concentration, 
indicating a significant introduction of bias.  The last finding reinforces the value of using 
ISO recommendations as a minimum for regulating pipette performance, as the complete 
lack of compliance with the nominal concentration would undermine the value of any 
labor performed with these pipettes.  Similar to Table 9, Table 10 provides a summary of 
the percent errors associated with the dilution series under various states of control across 
all four dilutions: 
 Table 10. Summary of percent errors for the 2-pipette simulation across various states of control.  
Displayed are the percent errors of the calculated average concentrations of the 4 dilutions across various 
states of control for the 2-pipette dilution simulation. 
Dilution In Shewhart and 
ISO Control (%) 
Out of Shewhart and 
in ISO Control (%) 
Out of Shewhart and 
ISO Control (%) 
1
st
 Dilution 0.358 0.636 1.805 
2
nd
 Dilution 0.705 1.295 3.654 
3
rd
 Dilution 1.063 1.925 5.519 
4
th
 Dilution 1.394 2.540 7.446 
 
Although not as dramatic as the values displayed in Table 9, the percent errors shown in 
Table 10 indicate that percent errors increase as the level of control decreases.  This 
suggests that within a two-pipette system, much like a single pipette system, the use of 
Shewhart control lines may reduce the accumulation of error across wide dilutions ranges 
better than ISO controls alone.  
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4. CONCLUSIONS 
This paper aims to determine the applicability of Shewhart charts to pipette 
calibrations as a means to monitor stability across time.  To this end, eight years of 
pipette calibration data, for a total of 71 pipettes of various volumes, were collected and 
consolidated into a series of    and S charts.  Shewhart charts alone are not well suited to 
assess whether pipettes are in calibration, as the control limits imposed by the charts shift 
to encircle the experimental grand mean and may not reflect the nominal volume of the 
pipette’s setting, and thus may not be within the bounds of the ISO8655 
recommendations.  However, they show promise as a supplement to the calibration 
standards outlined by ISO8655.  In particular, Shewhart charts show the sample means 
and the grand mean of each pipette, allowing for simple comparison to the nominal 
volume settings, which would prove useful for the identification of potential systematic 
bias.  Additionally, Shewhart charts can serve to identify gross shifts in pipette 
performance that fall within ISO8655 calibration but nevertheless may negatively impact 
pipette performance in casework.   
The addition of a lower control limit for the standard deviation in the S chart is 
also promising, as it offers the ability to assess pipette calibration data for errors and 
outliers in the standard deviation, a need demonstrated by the raw data as the charts were 
being produced.  Other potential applications for Shewhart charts include training and the 
assessment of operator skill, including as a pass-fail criterion or monitoring progress over 
a learning period.  With a Shewhart chart displaying a pipette’s most recent calibration 
data, it would be possible to compare an operator’s performance to the pipette’s expected 
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volume delivery.  With this tool, it would be possible to statistically gauge an operator’s 
relative level of skill at manual pipetting and identify operators that require additional 
training or supervision.  Further research is necessary to allow for the full implementation 
of Shewhart charts into routine pipette maintenance.   
The aim of the serial dilution series and the Stella simulations was to elucidate 
whether the systematic errors projected by the charts would impact actual laboratory 
work.  A series of four serial dilutions was performed with CF-1 and measured on a 
NanoDrop spectrophotometer to investigate for potential pipetting bias across the 
dilutions.  A series of Stella simulations was performed to explore additional scenarios 
for pipettes in various states of control.  While the Stella simulations consistently 
supported the value of Shewhart charts to correctly monitor pipette performance in 
relation to the nominal volume delivery, the dilution study offered inconsistent evidence 
of systematic pipetting bias.  The measurements taken with the pedestal method only 
showed potential bias in the 4
th
 dilution, while the measurements taken with the cuvette 
showed potential bias in the first three dilutions but not in the 4
th
.  It is not clear whether 
these inconsistencies reflect potential pipetting bias and its impact on subsequent steps or 
whether these inconsistencies indicate a confounding factor. 
Nevertheless, Shewhart charts show promise as a supplementary tool for pipette 
stability monitoring.  As demonstrated by the simulations for the pipette J12776B and the 
two-pipette system, significant percent errors may accumulate for pipettes operating 
within ISO control, further reinforcing the usefulness of Shewhart charts as an additional 
layer of control.    
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4.1 Future Research 
More refinement is required before the full employment of Shewhart charts in 
pipette calibration stability can be implemented.  The scope of this study is limited to 
investigating whether Shewhart charts are a promising method for the analysis of pipette 
stability over time.  The charts and control limits herein are not suitable for identifying 
in-control versus out-of-control calibrations.  Questions remain as to whether the 
systematic bias displayed in the Shewhart charts is statistically significant.   
Further questions remain as to how manual pipetting from a skilled user may 
compare to a programmable pipetting machine.  Such an undertaking would require new, 
independently-gathered recalibrations of all the pipettes by a single investigator in order 
to produce Shewhart charts suitable for in-control versus out-of-control analysis on 
calibration data.  In conclusion, Shewhart charts have the potential to supplement 
ISO8655 recommended limits for the purposes of pipette calibration and stability 
assessments.  If successful, Shewhart charts may allow for the simple identification of 
pipettes that may be in need of recalibration, the identification of systematic bias, and the 
assessment of user’s manual pipetting skill.   Further research is also required to support 
or refute whether pipetting bias may introduce demonstrable experimental error in 
subsequent procedures.    
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APPENDIX A:     
Table A. List of All Pipettes Examined 
Pipette Serial Number Pipette Size (µL) Set Name 
CH50668 1-10 Amp Setup R800 
P18030B 1-10 Amp Setup R800 
AA93953 1-10 Analysis Set 1 R801 
GJ10447 1-10 Analysis Set 1 R801 
CH47677 1-10 Electrochem R807 
CH66867 1-10 Ext Set 1 R805 
401120A 1-10 Ext Set 2 R805 
CH50244 1-10 Ext Set 2 R805 
CH45083 1-10 Ext Set 2 R805 
CH50237 1-10 Ext Set 3 R805 
CH47664 1-10 Ext Set 4 R805 
CH32371 1-10 For. Amp Setup R800 
CH50671 1-10 For. Analysis Set 1 R801 
GH84439 1-10 For. Analysis Set 1 R801 
CH84439 1-10 For. Ext Set 1 R805 
CH84435 1-10 For. Ext Set 2 R805 
CH89198 1-10 (multi-channel) Analysis Set 1 R801 
EH84868 1-10 (multi-channel) Analysis Set 1 R801 
CH54605 1-10 (multi-channel) For. Amp Setup R800 
CH37289 1-10 (multi-channel) For. Analysis Set 1 R801 
I11488B 10-100 Amp Setup R800 
DH10306 10-100 Chem Room R810 
CH68041 10-100 For. Ext Set 1 R805 
CH80348 100-1000 Amp Setup R800 
CH80353 100-1000 Analysis Set 1 R801 
J12776B 100-1000 Analysis Set 1 R801 
011002B 100-1000 Electrochem R807 
EH12736 100-1000 Electrochem R807 
CH53567 100-1000 Ext Set 1 R805 
EH57384 100-1000 Ext Set 1 R805 
CH53592 100-1000 Ext Set 2 R805 
CH53587 100-1000 Ext Set 3 R805 
CH80808 100-1000 Ext Set 3 R805 
CH80364 100-1000 For. Amp Setup R800 
CH80812 100-1000 For. Analysis Set 1 R801 
CH53591 100-1000 For. Ext Set 1 R805 
CH80833 100-1000 For. Ext Set 2 R805 
CJ04207 1-3 Amp Setup R800 
CJ04208 1-3 Amp Setup R800 
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Pipette Serial Number Pipette Size (µL) Set Name 
CH59127 1-3 Ext Set 2 R805 
CJ14238 1-3 Ext Set 3 R805 
CJ20298 1-3 Ext Set 4 R805 
CJ19245 1-3 For. Analysis Set 1 R801 
CJ04204 1-3 For. Ext Set 1 R805 
CH59131 1-3 For. Ext Set 2 R805 
CH88179 30-300 Amp Setup R800 
HH09017 30-300 Amp Setup R800 
CH95831 30-300 Analysis Set 1 R801 
EH73474 30-300 Analysis Set 1 R801 
DH62286 30-300 Electrochem R807 
CH95828 30-300 Ext Set 1 R805 
CH95835 30-300 Ext Set 2 R805 
CJ29359 30-300 Ext Set 3 R805 
CH66488 30-300 Ext Set 4 R805 
CH95817 30-300 For. Amp Setup R800 
DH11374 30-300 For. Analysis Set 1 R801 
CH88175 30-300 For. Ext Set 1 R805 
CH51303 5-50 Amp Setup R800 
CH51302 5-50 Analysis Set 1 R801 
DH10902 5-50 Electrochem R807 
CH63131 5-50 Ext Set 1 R805 
CH63134 5-50 Ext Set 2 R805 
CH75869 5-50 Ext Set 3 R805 
CH63110 5-50 Ext Set 4 R805 
CH51292 5-50 For. Amp Setup R800 
DH18085 5-50 For. Analysis Set 1 R801 
CH63130 5-50 For. Ext. Set 2 R805 
CH54595 5-50 (multi-channel) For. Amp Setup R800 
DH49860 500-5000 Chem Room R810 
DH49862 500-5000 Chem Room R810 
CH65534 500-5000 Electrochem R807 
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